Tendinopathy: How to Prep for Your First Visit

What Tendinopathy Actually Is (and Why It Matters Before Your Visit)

Tendinopathy describes a spectrum of failed tendon healing marked by collagen disorganization, neovascularization, and increased ground substance, with minimal classical inflammatory infiltrate on histology. Understanding this distinction shapes every decision your clinician will make.

The word "tendinitis" implies active inflammation. Histological studies of chronic tendon pain samples show a conspicuous absence of inflammatory cells, with the predominant finding being disorganized type-I collagen and angiofibroblastic hyperplasia instead. Maffulli N et al., JAMA 1998 introduced the term "tendinopathy" precisely because pathology does not match the "-itis" label.

This matters to you, the patient, because NSAIDs, cortisone injections, and rest may quiet symptoms short-term but do not restore tendon structure. Arriving at your first appointment already knowing that your tendon needs progressive mechanical load, not mere inflammation suppression, will help you ask better questions and accept a more demanding rehab plan.

The Four Most Common Sites

Tendons most often affected are the Achilles (insertional and mid-portion), patellar (jumper's knee), rotator cuff (supraspinatus), and the common extensor origin at the lateral epicondyle. Each site has slightly different biomechanical drivers and loading protocols, so naming your exact location clearly saves time.

How Symptoms Progress

Most patients describe a predictable arc: morning stiffness that "warms up," pain only at the start or end of activity, and then constant pain that limits daily tasks. The Victorian Institute of Sport Assessment (VISA) questionnaire scores this arc from 0 to 100 and is used in research and clinical practice to track severity over time. Visentini PJ et al., J Sci Med Sport 1998 validated the Achilles-specific VISA-A score, which your clinician may ask you to complete before or during the visit.

Building Your Pain Timeline Before the Appointment

A precise timeline is the single most useful thing you can bring. Clinicians use it to estimate whether the tendon is reactive (acute, 0-6 weeks), in tendon dysrepair (6 weeks to 3 months), or degenerative (beyond 3 months), a staging model proposed by Cook and Purdam in their 2009 continuum model. Cook JL, Purdam CR, Br J Sports Med 2009

What to Record

Write down:

• The exact date or week symptoms began
• The activity or change in training load that preceded onset (new shoes, increased weekly mileage, sudden return to sport)
• Any prior episodes in the same tendon, with approximate dates
• What makes it worse (hills, stairs, throwing, gripping) and what provides relief
• Treatments already tried: rest, ice, NSAIDs, physiotherapy, cortisone, orthotics, and for how long each was used

A simple table on your phone works well. You do not need a formal document.

The Load-Change Principle

Research across multiple tendon sites consistently shows that a rapid spike in mechanical load, whether from too much volume, too much intensity, or a sudden return after rest, is the most common precipitant. Gabbett TJ, Br J Sports Med 2016 described this as the "acute:chronic workload ratio" problem. Your clinician will want to know your typical weekly training load in the 8 weeks before symptoms appeared compared with the 4 weeks that immediately preceded onset.

Imaging and Prior Records: What to Bring

Diagnostic Ultrasound vs. MRI

Both ultrasound and MRI detect tendon thickening, hypoechoic zones, and partial tears. Diagnostic ultrasound has the advantage of dynamic assessment and is the first-line imaging modality recommended by the British Journal of Sports Medicine consensus for Achilles tendinopathy. Beyer R et al., Am J Sports Med 2015 used ultrasound-confirmed mid-portion Achilles tendinopathy as an entry criterion in their RCT comparing heavy slow resistance vs. Eccentric training.

If you have had prior imaging, bring the original CD or digital files, not just the report. Radiologists read images in isolation; your clinician may interpret the same scan differently in the context of your physical exam findings.

Labs and Medication List

Certain systemic conditions mimic or worsen tendinopathy: hypothyroidism, diabetes mellitus, hypercholesterolemia, and gout have all been associated with tendon pathology. Gaida JE et al., Scand J Med Sci Sports 2009 found that hyperlipidemia independently predicted Achilles tendon abnormality on ultrasound. Bring any recent metabolic labs.

Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin) carry an FDA black box warning for tendon rupture risk. FDA Drug Safety Communication 2016 specifically updated labeling to include tendinitis and tendon rupture. If you have taken a fluoroquinolone in the past 6 months, tell your clinician immediately, as this changes both diagnosis and treatment strategy.

What the Physical Exam Will Cover

Expect a 15-to-20-minute hands-on assessment. Your clinician will palpate the tendon along its full length to locate the maximum pain point, distinguishing insertional from mid-portion pathology. A positive arc sign (pain with mid-range passive ankle dorsiflexion that disappears at end range) supports mid-portion Achilles involvement specifically.

Provocation Tests by Site

• Achilles: Single-leg heel raise to failure, Matles test, Thompson squeeze test (rules out rupture)
• Patellar: Victorian Institute of Sport Assessment for Patella (VISA-P), single-leg decline squat
• Lateral epicondyle: Cozen's test, Mill's test, grip strength dynamometry
• Rotator cuff: Hawkins-Kennedy, empty-can, Neer sign; combined sensitivity for supraspinatus tear exceeds 80% in meta-analysis. Hegedus EJ et al., Br J Sports Med 2008

Strength and Movement Screen

Tendinopathy rarely exists in isolation. Hip abductor weakness, ankle dorsiflexion restriction, and altered running mechanics are frequent contributors. Your clinician may run a brief movement screen to identify these upstream drivers, since correcting them reduces reloading of the tendon.

First-Line Treatment: What the Evidence Says

Progressive Tendon Loading

Progressive loading is the best-supported intervention for tendinopathy across all sites. The Alfredson eccentric heel-drop protocol (3 sets of 15 repetitions twice daily, 12 weeks, on a decline board for mid-portion Achilles) produced a 60% reduction in pain and improved function in the original case series of 15 patients. Alfredson H et al., Am J Sports Med 1998

Later work by Beyer et al. (N=58) compared eccentric-only training with heavy slow resistance (HSR) training at 12 weeks and found equivalent pain outcomes (VISA-A scores: 80.0 vs. 79.0 points) with higher patient satisfaction in the HSR group. Beyer R et al., Am J Sports Med 2015 Neither protocol used passive rest.

The key principle: the tendon must be loaded to the point of mild, acceptable pain (3/10 on a numeric rating scale) to stimulate collagen synthesis. Completely avoiding pain produces worse outcomes than graded loading.

Load Management Principles

Complete rest is contraindicated for most presentations. Your clinician will prescribe a "continue to train, but modify" approach. Isometric contractions (sustained holds of 45 seconds, 5 repetitions) reduce tendon pain acutely and are useful for in-season athletes who cannot reduce training volume. Rio E et al., Br J Sports Med 2015

Corticosteroid Injections: Short-Term Help, Long-Term Risk

A single cortisone injection provides faster short-term pain relief than physiotherapy alone but is associated with worse outcomes at 1 year compared with eccentric exercise. Coombes BK et al., JAMA 2010 reported this pattern for lateral epicondylopathy specifically (N=165), with a relative risk of recurrence of 2.35 at 1 year for the injection group. Repeat injections are generally avoided due to risk of collagen necrosis and tendon rupture.

Emerging and Off-Label Options: PRP, Sclerosing Injections, and BPC-157

Platelet-Rich Plasma (PRP)

PRP involves concentrating autologous platelets and injecting the growth-factor-rich plasma into the damaged tendon under ultrasound guidance. The rationale is that platelet-derived growth factor (PDGF) and transforming growth factor beta-1 (TGF-b1) may stimulate tenocyte activity.

A 2013 Cochrane review found insufficient evidence to recommend or reject PRP for tendinopathy but noted that several trials showed clinically meaningful pain reduction at 6 months. de Vos RJ et al., Cochrane Database 2010 (updated) More recent data from Gosens et al. Showed that leukocyte-rich PRP outperformed corticosteroid at 2 years for lateral epicondylopathy. PRP is not FDA-approved for tendinopathy specifically, but the preparation devices are cleared as Class II devices.

Sclerosing Injections (Polidocanol)

Neovascularization visible on Doppler ultrasound is associated with pain in tendinopathy. Polidocanol injected into neovascular zones disrupts this aberrant blood supply and has shown benefit in randomized trials for mid-portion Achilles tendinopathy. Hoksrud A et al., Am J Sports Med 2006 (N=33) reported 70% of the sclerosing group were satisfied vs. 30% in the placebo group at 12 weeks.

BPC-157: Current Evidence and Limitations

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a gastric protein in humans. Animal studies show accelerated tendon-to-bone healing through upregulation of the nitric oxide system and growth hormone receptor expression. Pevec D et al., J Orthop Res 2010 demonstrated faster transected quadriceps tendon healing in rats given BPC-157 intraperitoneally compared with controls.

No completed randomized controlled trials in humans have been published as of mid-2025. BPC-157 is not FDA-approved and is classified as a research compound. Compounding pharmacies in the United States may prepare it, but the FDA has expressed concern about peptide compounds being added to the 503B outsourcing facility bulk list without approved NDAs.

The HealthRX clinical framework for discussing BPC-157 with patients divides candidates into three tiers:

Tier 1 (not appropriate): Patients who have not yet completed a minimum 12-week progressive loading program. Loading evidence is Grade A; BPC-157 evidence in humans is Grade D at best.

Tier 2 (may be appropriate for discussion): Patients who have completed two full loading cycles (24+ weeks total), failed PRP at one site, and have a documented partial tear on MRI or ultrasound with ongoing pain above 5/10.

Tier 3 (individualized decision with full informed consent): Competitive athletes with clear structural pathology, a documented failure of all Grade A and Grade B interventions, and willingness to accept an off-label experimental protocol with quarterly monitoring.

This framework is not a prescription protocol. It is a decision scaffold intended to ensure that no patient receives BPC-157 before exhausting evidence-based options.

Questions to Ask at Your First Visit

Arriving with prepared questions changes the dynamic from passive recipient to active partner. These eight questions are specific enough to generate clinically useful answers:

1. Is my tendon reactive, in dysrepair, or degenerative, based on the continuum model?
2. Which loading protocol will you prescribe, eccentric-only or heavy slow resistance, and why for my specific tendon?
3. Should I modify my current training load now, or stop entirely?
4. Do I need ultrasound today, or can we start treatment and image at 6 weeks if I do not respond?
5. Is there a structural finding (partial tear, calcification, insertional bursitis) that changes the plan?
6. What is my VISA score today, and what score should I reach before returning to full sport?
7. At what point would you consider PRP, and what would the protocol be?
8. Are there systemic contributors, lipids, thyroid, blood glucose, that I should address in parallel?

Red Flags That Change Everything

Some findings at your first visit indicate a different diagnosis or an urgent intervention. Report these to your clinician before the physical exam:

• Sudden onset with a "pop" or "snap": Suggests partial or complete rupture, not tendinopathy
• Nocturnal pain unrelated to position: Raises concern for inflammatory arthropathy (spondyloarthritis, psoriatic arthritis) or occult neoplasm
• Systemic symptoms: Fever, weight loss, morning stiffness lasting more than 45 minutes
• Recent fluoroquinolone use: As noted above, FDA black-box warning applies; tendon is biomechanically compromised even if pain has not yet appeared
• Swelling, redness, warmth at rest: Septic tenosynovitis requires urgent surgical consult, not outpatient rehab

The British Journal of Sports Medicine's 2018 clinical framework for tendon pain explicitly lists inflammatory arthropathy as the primary condition to exclude before starting a tendon-loading program. Silbernagel KG et al., Br J Sports Med 2019

Setting Realistic Expectations for Recovery

Mid-portion Achilles tendinopathy managed with a progressive loading program takes 12 to 24 weeks to achieve VISA-A scores above 80 (out of 100) in most patients. Patellar tendinopathy in competitive jumping athletes often requires 16 to 24 weeks with full compliance before return to unrestricted sport.

"Tendon pain can be managed in the short term with symptom modification, but structural change requires months of consistent loading," according to the 2019 consensus statement on tendinopathy management published in the British Journal of Sports Medicine. Docking SI, Cook J, Br J Sports Med 2019

Partial symptom improvement at 6 weeks does not mean the tendon has healed structurally. Patients who stop loading at this point account for a large proportion of recurrences.

The 2023 NICE guideline on tendinopathy (evidence review NG234) states: "Exercise therapy, particularly eccentric and heavy slow resistance training, is recommended as the core intervention for all tendon sites, with a minimum duration of 12 weeks before considering invasive procedures." This standard should anchor your expectations from visit one.